Primary ipilimumab/nivolumab followed by adjuvant nivolumab in patients with locally advanced or oligometastatic melanoma: Update on outcome

Cocorocchio, E; Gandini, S; Nezi, L; Manzo, T; Mazzarella, L; Barberis, M; Lanfrancone, L; Pala, L; Conforti, F; Pennacchioli, E; Orsolini, G; Fierro, Mt; Quaglino, P; Senetta, R; Caliendo, V; Stucchi, Crs; Macandog, Ad; Frige, G; Ferrucci, Pf